However, other studies demonstrated that downregulation of DUSP9 promotes tumor progression and contributes to poor prognosis in colorectal cancer [63], and DUSP9 silencing activates JNK signaling to promote cell proliferation in human gastric cancer [64]. Here, MAPK8 is linked to neoplasm.